Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Opraskin was a registered trademark (Registration #2108104) owned by Lohmann GmbH & Co. KG, filed in the category of Pharmaceutical Products. The trademark was registered on October 28, 1997, but its status is currently "Dead/Cancelled" as of July 31, 2004. There is no available information regarding its specific mechanism of action, indications, or active pharmaceutical ingredients, suggesting it was either never fully commercialized or was discontinued.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Opraskin.